Real-time
BOERSE MUENCHEN
05:43:44 2024-07-16 am EDT
|
5-day change
|
1st Jan Change
|
40.4
EUR
|
0.00%
|
|
+1.51%
|
0.00%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,780
|
-
|
-
|
Enterprise Value (EV)
1 |
9,323
|
9,172
|
8,971
|
P/E ratio
|
31.6
x
|
29.9
x
|
27.6
x
|
Yield
|
1.09%
|
1.2%
|
1.27%
|
Capitalization / Revenue
|
3.12
x
|
2.97
x
|
2.81
x
|
EV / Revenue
|
3.32
x
|
3.1
x
|
2.87
x
|
EV / EBITDA
|
14.8
x
|
13.2
x
|
11.8
x
|
EV / FCF
|
37.6
x
|
31.7
x
|
26.6
x
|
FCF Yield
|
2.66%
|
3.16%
|
3.76%
|
Price to Book
|
10.7
x
|
8.67
x
|
7.16
x
|
Nbr of stocks (in thousands)
|
200,004
|
-
|
-
|
Reference price
2 |
43.90
|
43.90
|
43.90
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,678
|
2,810
|
2,957
|
3,125
|
EBITDA
1 |
-
|
628.6
|
696.2
|
760.4
|
EBIT
1 |
-
|
441.2
|
477.3
|
511
|
Operating Margin
|
-
|
15.7%
|
16.14%
|
16.35%
|
Earnings before Tax (EBT)
1 |
-
|
374.7
|
415
|
437.5
|
Net income
1 |
260
|
280.9
|
294.3
|
318.3
|
Net margin
|
9.71%
|
9.99%
|
9.95%
|
10.18%
|
EPS
2 |
-
|
1.390
|
1.467
|
1.591
|
Free Cash Flow
1 |
-
|
247.9
|
289.5
|
336.9
|
FCF margin
|
-
|
8.82%
|
9.79%
|
10.78%
|
FCF Conversion (EBITDA)
|
-
|
39.44%
|
41.58%
|
44.3%
|
FCF Conversion (Net income)
|
-
|
88.28%
|
98.38%
|
105.84%
|
Dividend per Share
2 |
-
|
0.4783
|
0.5283
|
0.5581
|
Announcement Date
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
670
|
719.7
|
702.9
|
710.2
|
697.2
|
757.8
|
EBITDA
1 |
131
|
170.1
|
158.1
|
163.8
|
143.6
|
191.8
|
EBIT
1 |
90
|
122.9
|
110.6
|
114.4
|
93.94
|
136.9
|
Operating Margin
|
13.43%
|
17.07%
|
15.74%
|
16.11%
|
13.47%
|
18.07%
|
Earnings before Tax (EBT)
1 |
73
|
105
|
94.33
|
102.3
|
78.5
|
125.5
|
Net income
1 |
56
|
77.98
|
71.4
|
76.44
|
54
|
89
|
Net margin
|
8.36%
|
10.83%
|
10.16%
|
10.76%
|
7.75%
|
11.74%
|
EPS
2 |
0.2800
|
0.3774
|
0.3583
|
0.3735
|
0.2749
|
0.4355
|
Dividend per Share
2 |
0.1300
|
0.1250
|
0.1250
|
0.1250
|
0.1275
|
0.1275
|
Announcement Date
|
5/20/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
543
|
392
|
191
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.8631
x
|
0.5625
x
|
0.2515
x
|
Free Cash Flow
1 |
-
|
248
|
290
|
337
|
ROE (net income / shareholders' equity)
|
-
|
37.6%
|
32.5%
|
28.9%
|
ROA (Net income/ Total Assets)
|
-
|
9.81%
|
9.8%
|
10.2%
|
Assets
1 |
-
|
2,864
|
3,004
|
3,132
|
Book Value Per Share
2 |
-
|
4.100
|
5.070
|
6.130
|
Cash Flow per Share
2 |
-
|
2.180
|
2.730
|
-
|
Capex
1 |
-
|
219
|
238
|
240
|
Capex / Sales
|
-
|
7.79%
|
8.07%
|
7.69%
|
Announcement Date
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
43.9
USD Average target price
41.75
USD Spread / Average Target -4.89% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.42% | 2.61B | | -21.53% | 2.4B | | -24.72% | 1.9B | | +30.18% | 1.08B | | -15.72% | 1B | | -18.71% | 930M | | -3.32% | 728M | | -32.02% | 633M | | -36.58% | 563M |
Testing Laboratories
|